One-year follow-up data suggest that a novel transcatheter tricuspid valve replacement (TTVR) device may provide another potential alternative to surgery for patients with severe tricuspid ...

The original LuX-Valve system was associated with 10.3% mortality and 4.0% hospitalization for heart failure at 1 year when used for transcatheter tricuspid valve replacement (TTVR) in 126 ...

The global flurry of innovation in tricuspid valve interventions continues in the wake of Evoque's release, as illustrated by the 1-year report for a Chinese-made device that has already ...